STAT

Opinion: People with serious illness can teach us a lot about living with Covid-19

An aerial view of a nearly empty street on the first day of a national quarantine on March 20 in Buenos Aires, Argentina.

As the U.S. grapples with a potentially deadly pandemic, it can learn a lot from people like me who are living with serious illness.

Before you throw tomatoes, hear me out. People who live every day with chronic, advanced, and complex illnesses can help shape public attitudes toward following guidelines to reduce the spread of Covid-19.

I say that because I believe that people coping with serious illness — advanced cancer, transplant recipients, heart failure, autoimmune conditions, and more — have a unique perspective to help the public respond to recommendations to decrease transmission of the novel coronavirus and maximize our commitment to each other during an uncertain time.

When the fear of illness is raised, in addition to the voices of government, public health, and medical

You’re reading a preview, subscribe to read more.

More from STAT

STAT2 min read
STAT+: Pharmalittle: We’re Reading About Sanofi Licensing Novavax’s Covid Shot, Moderna’s RSV Vaccine, And More
Sanofi said it has reached a licensing deal to sell Novavax’s Covid shot as well as to try to combine the vaccine with Sanofi’s own flu vaccine.
STAT2 min read
STAT+: Pharmalittle: We’re Reading About BIO’s China Challenge, Zepbound Shortages, And More
BIO's about-face in its relationship with WuXi AppTec illustrates the difficulty the biotech industry faces in dealing with an issue that is moving fast and forcefully.
STAT2 min read
STAT+: Pharmalittle: We’re Reading About A Boy Dying In Pfizer Trial; AstraZeneca Yanking Covid Shot, And More
A young boy died in a clinical trial for an experimental Pfizer gene therapy for Duchenne muscular dystrophy, about a year after receiving the therapy.

Related Books & Audiobooks